sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Interests in Mural Oncology
The Vanguard Group, Inc. has disclosed its interests in Mural Oncology plc under Form 8.3, as required by the Irish Takeover Panel. The disclosure indicates that Vanguard holds relevant securities, amounting to 1.67% of $0.01 ordinary shares, equating to 288,907 shares.
As of October 29, 2025, Vanguard is not party to any other interests or short positions beyond those reported. The document indicates that there were no significant derivative transactions or any other dealing arrangements in connection with Mural Oncology.
No agreements, formal or informal, inducing dealing or refraining from dealing in the securities were reported. Additionally, there are no supplemental attachments or further undertakings associated with this disclosure.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.